ProQR to Release Topline Data from Proof of Concept Study of QR-010 in Cystic Fibrosis Patients at NACFC Press release LEIDEN, the Netherlands, June 21, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. juni 21, 2016
ProQR Announces Axiomer® RNA Editing Licensing and Research Collaboration with Lilly Press release Companies will collaborate to develop editing oligonucleotides directed to up to five targets using ProQR’s proprietary Axiomer® RNA edit september 08, 2021
ProQR Supports Rare Disease Day 2018 and Honors Henri A. Termeer Press release LEIDEN, the Netherlands, Feb. 27, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. februari 27, 2018
ProQR Announces Presentations and Investor & Analyst Event at the North American Cystic Fibrosis Conference Press release LEIDEN, the Netherlands, Oct. 24, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. oktober 24, 2017
ProQR Strengthens its Scientific Advisory Board with the Appointment of Dr. Phil Zamore, Dr. Cy Stein and Dr. Scott Armstrong Press release Key Updates augustus 28, 2017
ProQR Receives Fast Track Designation from the FDA for QR-110 for Leber’s Congenital Amaurosis Type 10 Press release Key Updates mei 31, 2017
ProQR Announces Annual General Meeting of Shareholders and Provides Leadership Updates Press release … co-founder of ProQR and previously served as ProQR’s Chief Innovation Officer from 2014 to 2022. John Maraganore, PhD, a … juni 01, 2022
ProQR Therapeutics to Host Virtual Analyst and Investor Event on December 11, 2024 Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 05, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. december 05, 2024
Lilly and ProQR to Expand RNA Editing Collaboration Press release New agreement supports the discovery and development of additional assets directed toward high conviction targets utilizing ProQR’s Axiomer technology december 22, 2022
ProQR Announces “ProQR Vision 2023” Strategy at its Annual R&D Day Press release LEIDEN, the Netherlands & CAMBRIDGE, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. januari 29, 2019